Login / Signup

Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.

Donavan T ChengMeera PrasadYvonne ChekalukRyma BenayedJustyna SadowskaAhmet ZehirAijazuddin SyedYan Elsa WangJoshua SomarYirong LiZarina YelskayaDonna WongMark E RobsonKenneth OffitMichael F BergerKhedoudja NafaMarc LadanyiZarina Yelskaya
Published in: BMC medical genomics (2017)
This study highlights the importance of the NGS-based gene panel testing approach in comprehensively identifying germline variants contributing to cancer predisposition and simultaneous detection of somatic and germline alterations.
Keyphrases